BIB vs TBXU

ProShares Ultra NASDAQ Biotechnology against Direxion Daily Biotech Top 5 Bull 2X ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
21%
5 shared positions
Fee gap
3 bp
BIB is cheaper
1-year return gap
0.3 pts
TBXU is ahead
Larger fund
BIB
$102M

Side by side

BIBTBXU
FundProShares Ultra NASDAQ BiotechnologyDirexion Daily Biotech Top 5 Bull 2X ETF
IssuerProSharesDirexion
CategoryLeveraged EquityLeveraged Equity
Expense ratio0.95%0.98%
Assets$102M$2.6M
Average daily dollar volume$997K$66K
ListedApr 6, 2010Sep 30, 2025
FrenzyCap score4721
1-month return+4.5%+20.5%
3-month return+5.7%+18.6%
Year to date+45.6%+53.9%
1-year return+52.7%+52.9%
30-day volatility61.5%53.0%
Worst drawdown, 1 year−17.9%−26.8%
Trailing 12-month yield0.19%1.60%
Holdings25411
Top 10 weight156.9%200.0%
Look-through P/E—40.9
Holdings vs fair value+8.4%+8.0%
Holdings above 200-day average82%100%
Net flow, latest 3 reported months+$1.5M thru Aug 2026−$873K thru Jul 2026
30-day implied volatility50.9%—
Holdings as ofas of Nov 13, 2026issuer dataas of Nov 13, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

21% of BIB · 55% of TBXU
HoldingBIBTBXU
GILD5.76%11.40%
AMGN5.43%12.07%
VRTX4.96%10.28%
REGN3.97%11.90%
ARGX1.08%9.73%

Sector mix of the stock holdings

SectorBIBTBXUGap
Health Care61.2%55.4%+5.8%
Technology2.1%0.0%+2.1%
Materials0.0%0.0%+0.0%

More: full overlap table · BIB holdings · TBXU holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.